$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Abstract AI-Helper 아이콘AI-Helper

The present study was designed to examine the effect of d-amphetamine on CA release from the isolated perfused model of the rat adrenal gland, and to establish its mechanism of action. Damphetamine $(10{\sim}100{\mu}M$), when perfused into an adrenal vein of the rat adrenal gland for 60 m...

주제어

참고문헌 (64)

  1. Akaike A, Mine Y, Sasa M, Takaori S. Voltage and current clamp studies of muscarinic and nicotinic excitation of the rat adrenal chromaffin cells. J Pharmacol Expt Ther 255: 333-339, 1990 

  2. Amador M, Dani JA. MK-801 inhibition of nicotinic acetylcholine receptor channels. Synapse 7: 207-215, 1991 

  3. Andersen PH. Biochemical and pharmacological characterization of $[^3H]$ GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. J Neurochem 48: 1887-1899, 1987 

  4. Anton AH, Sayre DF. A study of the factors affecting the aluminum oxide trihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360-375, 1962 

  5. Barrantes FJ, Antollini S, Massol R. Fluorescence studies of the nicotinic acetylcholine receptor in its membrane environment. Biosci Rep 19: 335-344, 1999 

  6. Bowyer JF, Masserano JM, Weiner N. Inhibitory effects of d-amphetamine on potassium-stimulated release of $[^3H]$ dopamine from striatal slices and synaptosomes J Pharmacol Exp Ther 240: 177-186, 1987 

  7. Bouzat C. Ephedrine blocks wild-type and long-lived mutant acetylcholine receptor channels. Neuroreport 8: 317-321, 1996 

  8. Burgoyne RD. Mechanism of secretion from adrenal chromaffin cells. Biochem Biophys Acta 779: 201-216, 1984 

  9. Burnette WB, Bailey MD, Kukoyi S, Blakely RD, Trowbridge CG, Justice Jr JB. Human norepinephrine transporter kinetics using rotating disk electrode voltammetry. Anal Chem 68: 2932-2938, 1996 

  10. Catterall WA. Structure and regulation of voltage-gated $Ca^{2+}$ channels. Annu Rev Cell Dev Biol 16: 521-555, 2000 

  11. Challis RAJ, Jones JA, Owen PJ, Boarder MR. Changes in inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate mass accumulations in cultured adrenal chromaffin cells in response to bradykinin and histamine. J Neurochem 56: 1083-1086, 1991 

  12. Cheek TR, Burgoyne RD. Cyclic AMP inhibits both nicotine-induced actin disassembly and catecholamine secretion from bovine adrenal chromaffin cells. J Biol Chem 262:11663-11666, 1987 

  13. Cheek TR, O'Sullivan AJ, Moreton RB, Berridge MJ, Burgoyne RD. Spatial localization of the stimulus-induced rise in cytosolic $Ca^{2+}$ in bovine adrenal chromaffin cells: Distinct nicotinic and muscarinic patterns. FEBS Lett 247: 429-434, 1989 

  14. Chen Y, Ogren, SO, Bjelke B, Bolme P, Eneroth P, Gross J, Loidl F, Herrera-Marschitz M, Andersson K. Nicotine treatment counteracts perinatal asphyxia-induced changes in the mesotriatal/ limbic dopamine systems and in motor behaviour in the fourweek- old male rat. Neuroscience 68: 531-538, 199512693 

  15. Dilger JP, Boguslavsky R, Barann M, Katz T, Vidal AM. Mechanisms of barbiturate inhibition of acetylcholine receptor channels. J Gen Physiol 109: 401-414. 1997 

  16. Gandia L, Borges R, Albillos A, Garcia AG. Multiple calcium channel subtypes in isolated rat chromaffin cells. Pflugers Arch 430: 55-63, 1995 

  17. Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, Gandia L. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature 309: 69-71, 1984 

  18. Goeger DE, Riley RT. Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on $Ca^{2+}$ binding and $Ca^{2+}$ permeability. Biochem Pharmacol 38: 3995-4003, 1989 

  19. Hammer R, Giachetti A. Muscarinic receptor subtypes: $M_1$ and $M_2$ biochemical and functional characterization. Life Sci 31: 2992-2998, 1982 

  20. Harish OE, Kao LS, Raffaniello R, Wakade AR, Shneider AS. Calcium dependence of muscarinic receptor-mediated catecholamine secretion from the perfused adrenal medulla. J Neurochem 48: 1730-1735, 1987 

  21. Hernandez-Guijo JM, Gandia L, de Pascual R, Garcia AG. Differential effects of the neuroprotectant lubeluzole on bovine and mouse chromaffin cell calcium channel subtypes. Br J Pharmacol 122: 275-285, 1997 

  22. Hurd YL, Ungerstedt U. $Ca^{2+}$ dependence of the d-amphetamine, nomifensine and Lu 19-005 effect on in vivo dopamine transmission. Eur J Pharmacol 166: 261-269, 1989 

  23. Ilno M. Calcium-induced calcium release mechanism in guinea pig taenia caeci. J Gene Physiol 94: 363-383, 1989 

  24. Inoue M, Kuriyama H. Muscarinic receptor is coupled with a cation channel through a GTP-binding protein in guinea-pig chromaffin cells. J Physiol (Lond) 436: 511-529, 1991 

  25. Karler R, Calder LD, Bedingfield JB. A novel nicotiniccholinergic role in behavioral sensitization to d-amphetamine-induced stereotypy in mice. Brain Res 725: 192-198, 1996 

  26. Kim KT, Westhead EW. Cellular responses to $Ca^{2+}$ from extracellular and intracellular sources are different as shown by simultaneous measurements of cytosolic $Ca^{2+}$ and secretion from bovine chromaffin cells. Proc Natl Acad Sci USA 86: 9881-9885, 1989.507 

  27. Kimura T, Shimamura T, Satoh S. Effects of pirenzepine and hexamethonium on adrenal catecholamine release in responses to endogenous and exogenous acetylcholine in anesthetized dogs. J Cardiovasc Pharmacol 20: 870-874, 1992 

  28. Knepper SM, Grunewald GL, Rutledge CO. Inhibition of norepinephrine transport into synaptic vesicles by d-amphetamine analogs. J Pharmacol Exp Ther 247: 487-494, 1988 

  29. Kujacic M, Carlsson A. Influence of GBR 12909 and d-amphetamine on indices of catecholamine synthesis and release in rat adrenal glands. Neuropharmacology 33: 983-987, 1994 

  30. Ladona MG, Aunis D, Gandia AG, Garcia AG. Dihydropyridine modulation of the chromaffin cell secretory response. J Neurochemstry 48: 483-490, 1987 

  31. Laruelle M, Abi-Dargham A, van Dyck C, Gil R, D'Souza DC, Krystal J, Seibyl J, Baldwin R, Innis R. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [123]beta-CIT. Biol Psychiatry 47: 371-379, 2000 

  32. Lim DY, Hwang DH. Studies on secretion of catecholamines evoked by DMPP and McN-A-343 in the rat adrenal gland. Korean J Pharmacol 27: 53-67, 1991 

  33. Lim DY, Kim CD, Ahn KW. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res 15: 115-125, 1992 

  34. Liu PS, Liaw CT, Lin MK, Shin SH, Kao LS, Lin LF. Damphetamine enhances $Ca^{2+}$ entry and catecholamine release via nicotinic receptor activation in bovine adrenal chromaffin cells. Eur J Pharmacol 460: 9-17, 2003 

  35. Mahata M, Mahata SK, Parmer RJ, O'Connor DT. Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion. Hypertension 28: 414- 420, 1996 

  36. Mercuri NB, Calabresi P, Bernardi G. The mechanism of damphetamine- induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro. Br J Pharmacol 98: 127-134, 1989 

  37. Milone M, Engel AG. Block of the endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine, and albuterol. Brain Res 740: 346-352, 1996 

  38. Misbahuddin M, Oka M. Muscarinic stimulation of guinea pig adrenal chromaffin cells stimulates catecholamine secetion without significant increase in $Ca^{2+}$ uptake. Neurosci Lett 87: 266-270, 1988 

  39. Mundorf ML, Hochstetler SE, Wightman RM. Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J Neurochem 73: 2397-2405, 1999 

  40. Nakazato Y, Oleshanskly M, Tomita U, Yamada Y. Voltageindependent catecholamine release mediated by the activation of muscarinic receptors in guinea-pig adrenal glands. Br J Pharmacol 93: 101-109, 1988 

  41. Oka M, Isosaki M, Yanagihara N. Isolated bovine adrenal medullary cells: studies on regulation of catecholamine synthesis and release. In: Usdin E, Kopin IJ, Brachas J ed, Catecholamines: Basic and Clinical frontiers. Pergamon Press, Oxford, p 70-72, 1979 

  42. Pierce RC, Kalivas PW. Repeated cocaine modifies the mechanism by which d-amphetamine releases dopamine. J Neurosci 17: 3254-3262, 1997 

  43. Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA. Mechanism of the dopamine-releasing actions of d-amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 47: 368-373, 1995 

  44. Pifl C, Agneter E, Drobny H, Sitte HH, Singer EA. D-amphetamine reverses or blocks the operation of the human noradrenaline transporter depending on its concentration: superfusion studies on transfected cells. Neuropharmacology 38: 157-165, 1999 

  45. Raiteri M, Bertollini A, Angelini F, Levi G. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther 208: 195-202, 1979 

  46. Richter JA, Bare DJ, Yu H, Ghetti B, Simon JR. Dopamine transporter-dependent and independent endogenous dopamine release from weaver mouse striatum in vitro. J Neurochem 64: 191-198, 1995 

  47. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223, 1987 

  48. Schneider FH. D-amphetamine-induced exocytosis of catecholamines from the cow adrenal medulla. J Pharmacol Exp Ther 183: 80-89, 1972 

  49. Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of $Ca^{2+}$ channels. Nature 303: 535-537, 1982 

  50. Seiden LS, Sabol KE, Ricaurte GA. D-amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33: 639-677, 1993 

  51. Seidler NW, Jona I, Vegh N, Martonosi A. Cyclopiazonic acid is a specific inhibitor of the $Ca^{2+}$ -ATPase of sarcoplasimc reticulum. J Biol Chem 264: 17816-17823, 1989 

  52. Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C. Carrier-mediated release, transport rates, and charge transfer induced by d-amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71: 1289-1297, 1998 

  53. Skau KA, Gerald MC. D-amphetamine inhibition of alpha-bungarotoxin binding at the mouse neuromuscular junction. Life Sci 20: 1495-1499, 1977 

  54. Spitzmaul GF, Esandi MC, Bouzat C. D-amphetamine acts as a channel blocker of the acetylcholine receptor. Neuroreport 10: 2175-2181, 1999 

  55. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A. D-amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15: 4102-4108, 1995 

  56. Suzuki M, Muraki K, Imaizumi Y, Watanabe M. Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum $Ca^{2+}$ -pump, reduces $Ca^{2+}$ -dependent $K^{+}$ currents in guinea-pig smooth muscle cells. Br J Pharmacol 107: 134-140, 1992 

  57. Tallarida RJ, Murray RB. Manual of pharmacologic calculation with computer programs. 2nd ed. Speringer-Verlag, New York, p 132, 1987 

  58. Uceda G, Artalejo AR, de la Fuente MT, Lopez MG, Albillos A, Michelena P, Garcia AG, Montiel C. Modulation by L-type $Ca^{2+}$ channels and apamin-sensitive $K^{+}$ channels of muscarinic responses in cat chromaffin cells. Am J Physiol 266(5 Pt 1): C1432-1439, 1994py19 

  59. Uyama Y, Imaizumi Y, Watanabe M. Effects of cyclopiazonic acid, a novel $Ca^{2+}$ -ATPase inhibitor on contractile responses in skinned ileal smooth muscle. Br J Pharmacol 106: 208-214, 1992 

  60. Wada Y, Satoh K, Taira N. Cardiovascular profile of Bay-K-8644, a presumed calcium channel activator in the dog. Naunyn- Schmiedebergs Arch Pharmacol 328: 382-387, 1985 

  61. Wakade AR. Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J Physiol 313: 463-480, 1981 

  62. Wayment H, Meiergerd SM, Schenk JO. Relationships between the catechol substrate binding site and d-amphetamine cocaine and mazindol binding sites in a kinetic model of the striatal transporter of dopamine in vitro. J Neurochem 70: 1941-1949, 1998 

  63. Wu X, Gu HH. Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene 233: 163-170, 1999 

  64. Yamada Y, Teraoka H, Nakazato Y, Ohga A. Intracellular $Ca^{2+}$ antagonist TMB-8 blocks catecholamine secretion evoked by caffeine and acetylcholine from perfused cat adrenal glands in the absence of extracellular $Ca^{2+}$ . Neurosci Lett 90: 338-342, 1988 

저자의 다른 논문 :

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로